{"id":57573,"date":"2024-02-27T17:50:34","date_gmt":"2024-02-27T17:50:34","guid":{"rendered":"https:\/\/medsname.com\/hydrosar\/"},"modified":"2026-04-30T10:24:24","modified_gmt":"2026-04-30T10:24:24","slug":"hydrosar","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/hydrosar\/","title":{"rendered":"Hydrosar"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Hydrosar?<\/h3>\n<p style=\"margin:0;\"><strong>Hydrosar<\/strong> este o capsul\u0103 oral\u0103 de la Sarabhai Chemicals care con\u021bine <strong>hidroxiuree (hidroxicarbamid\u0103) 500 mg<\/strong> \u2014 un inhibitor al ribonucleotide-reductazei utilizat pentru <strong>leucemia mieloid\u0103 cronic\u0103, policitemie vera, trombocitemie esen\u021bial\u0103, boala cu celule falciforme<\/strong>, \u0219i mai multe tumori solide (cap &amp; g\u00e2t, melanom). Dozarea standard pentru adul\u021bi variaz\u0103 \u00een func\u021bie de indica\u021bie: de obicei <strong>15\u201330 mg\/kg\/zi<\/strong> \u00een hematologie; <strong>20\u201335 mg\/kg\/zi<\/strong> \u00een boala cu celule falciforme. Monitorizare obligatorie: <strong>NFS la fiecare 2 s\u0103pt\u0103m\u00e2ni ini\u021bial, apoi lunar<\/strong> \u2014 titra\u021bi p\u00e2n\u0103 la ANC &gt; 2.000\/\u00b5L \u0219i trombocite &gt; 100.000\/\u00b5L. Contraindica\u021bie \u00een sarcin\u0103; contracep\u021bie sigur\u0103 la ambele sexe pe toat\u0103 durata tratamentului. Preocupare pe termen lung: ulcera\u021bii la picioare (cronice, dureroase), carcinom cutanat scuamos, posibil\u0103 leucemie secundar\u0103 (controversat, \u00een principal \u00een policitemia vera pe termen lung).<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 24px 0;border-radius:4px;font-size:14px;\"><strong>\u26a0 Supraveghere specializat\u0103 necesar\u0103.<\/strong> Medicamentele pentru cancer trebuie prescrise de un oncolog tratant, cu un diagnostic confirmat, stadializare ini\u021bial\u0103 \u0219i un plan de tratament definit. Nu \u00eencepe\u021bi, nu opri\u021bi, nu modifica\u021bi doza \u0219i nu utiliza\u021bi medicamente pentru cancer \u00een afara unui plan de \u00eengrijire condus de oncologie. Majoritatea medicamentelor pentru cancer necesit\u0103 monitorizare regulat\u0103 prin analize de s\u00e2nge (hemoleucogram\u0103, teste hepatice, func\u021bie renal\u0103), sunt absolut contraindicate \u00een sarcin\u0103 \u0219i au interac\u021biuni medicamentoase semnificative.<\/div>\n<div style=\"background:#f4f8fb;border:1px solid #d6e4ec;padding:12px 18px;margin:14px 0;border-radius:4px;font-size:14px;color:#3a5160;text-align:center;\">\n<strong>\ud83d\udd12 Checkout criptat<\/strong> \u00b7 <strong>\ud83d\udcb3 Procesor verificat<\/strong> \u00b7 <strong>\ud83d\ude9a Livrare worldwide<\/strong> \u00b7 <strong>\u2b50 4,9\/5 de la peste 1.400 de clien\u021bi<\/strong>\n<\/div>\n<h2 class=\"wp-block-heading\">Ce este Hydrosar?<\/h2>\n<p>Hydrosar este o capsul\u0103 oral\u0103 de la Sarabhai Chemicals care con\u021bine <strong>hidroxiuree 500 mg<\/strong> (denumit\u0103 \u0219i hidroxicarbamid\u0103). Hidroxiureea inhib\u0103 ribonucleotid-reductaza, bloc\u00e2nd sinteza ADN-ului. Este unul dintre cele mai utilizate \u0219i mai vechi agen\u021bi citoreductivi, cu un istoric de siguran\u021b\u0103 clinic\u0103 de 60 de ani \u00een maladiile hematologice, boala cu celule falciforme \u0219i mai multe tumori solide.<\/p>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri \u0219i indica\u021bii<\/h2>\n<ul>\n<li><strong>Leucemie mieloid\u0103 cronic\u0103<\/strong> \u2014 citoreduc\u021bie la diagnosticare sau ca alternativ\u0103 c\u00e2nd TKI (imatinib etc.) nu pot fi utiliza\u021bi<\/li>\n<li><strong>Policitemie vera<\/strong> \u2014 citoreduc\u021bie de prim\u0103 linie \u00een boal\u0103 cu risc crescut<\/li>\n<li><strong>Trombocitemie esen\u021bial\u0103<\/strong> \u2014 citoreduc\u021bie de prim\u0103 linie \u00een boal\u0103 cu risc crescut<\/li>\n<li><strong>Mielofibroz\u0103 (faza timpurie)<\/strong> \u2014 controlul simptomelor \u0219i al num\u0103r\u0103rilor<\/li>\n<li><strong>Boala cu celule falciforme<\/strong> \u2014 reduce frecven\u021ba crizelor vaso-occlusive \u0219i a sindromului toracic acut; cre\u0219te HbF<\/li>\n<li><strong>Leucemie acut\u0103 \u2014 leucocitoz\u0103 de urgen\u021b\u0103<\/strong> reducere (citoreduc\u021bie rapid\u0103 \u00eenaintea terapiei definitive)<\/li>\n<li><strong>Carcinom scuamos de cap \u0219i g\u00e2t<\/strong> \u2014 cu radioterapie concomitent\u0103 (regimuri mai vechi)<\/li>\n<li><strong>Melanom, cancer ovarian (utilizare limitat\u0103 \u00een practica modern\u0103)<\/strong><\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Doza \u0219i mod de administrare<\/h2>\n<p>Doza variaz\u0103 \u00een func\u021bie de indica\u021bie. Exemple pentru adul\u021bi:<\/p>\n<ul>\n<li><strong>CML, ET, PV citoreduc\u021bie:<\/strong> \u00eencepe cu 15 mg\/kg\/zi; ajusteaz\u0103 la 15\u201330 mg\/kg\/zi \u00een func\u021bie de num\u0103r\u0103toare<\/li>\n<li><strong>Anemia falciform\u0103:<\/strong> \u00eencepe cu 15 mg\/kg\/zi; cre\u0219te cu 5 mg\/kg\/zi la fiecare 8 s\u0103pt\u0103m\u00e2ni p\u00e2n\u0103 la maximum 35 mg\/kg\/zi sau doza maxim\u0103 tolerat\u0103<\/li>\n<li><strong>Citoreduc\u021bie de urgen\u021b\u0103 \u00een leucemie acut\u0103:<\/strong> 50\u2013100 mg\/kg\/zi timp de 1\u20132 zile (sub supraveghere specializat\u0103)<\/li>\n<\/ul>\n<ol>\n<li>Administra\u021bi o dat\u0103 sau de dou\u0103 ori pe zi conform prescrip\u021biei, cu sau f\u0103r\u0103 alimente.<\/li>\n<li>\u00cenghi\u021bi\u021bi capsulele \u00eentregi. <strong>NU deschide\u021bi capsulele<\/strong> \u2014 pulberea este citotoxic\u0103 \u0219i d\u0103un\u0103toare la contact. Dac\u0103 o capsul\u0103 nu poate fi \u00eenghi\u021bit\u0103, con\u021binutul poate fi dispersat \u00een ap\u0103, iar \u00eengrijitorul trebuie s\u0103 poarte m\u0103nu\u0219i \u0219i s\u0103 evite contactul cu pielea\/ochii.<\/li>\n<li><strong>Monitorizare obligatorie:<\/strong> NFS la fiecare 2 s\u0103pt\u0103m\u00e2ni ini\u021bial (sau s\u0103pt\u0103m\u00e2nal \u00een timpul titr\u0103rii la anemia falciform\u0103), apoi lunar. U&amp;E + teste hepatice la fiecare 1\u20133 luni. Num\u0103r\u0103toare de reticulocite, HbF (anemia falciform\u0103). MCV cre\u0219te la hidroxiuree (un marker util al conformit\u0103\u021bii).<\/li>\n<li>Ajustarea dozelor \u00een func\u021bie de num\u0103r\u0103toare: \u00eentrerupe\u021bi pentru ANC &lt; 2.000\/\u00b5L, trombocite &lt; 80.000\/\u00b5L sau Hb &lt; 4,5 g\/dL. Relua\u021bi cu doz\u0103 mai mic\u0103 dup\u0103 recuperare.<\/li>\n<li>Acid folic 5 mg zilnic este adesea prescris concomitent (\u00een special \u00een hemoglobinopatii).<\/li>\n<li>Consuma\u021bi suficiente lichide pentru a reduce riscul de hiperuricemie \u0219i sindrom de liz\u0103 tumoral\u0103.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Frecvente:<\/strong> mielosupresie (efectul dorit la doza terapeutic\u0103), grea\u021b\u0103, anorexie, mucozit\u0103, diaree u\u0219oar\u0103, hiperpigmentare cutanat\u0103, pigmentare unghial\u0103, sub\u021bierea p\u0103rului.<\/p>\n<p><strong>Important:<\/strong><\/p>\n<ul>\n<li><strong>Ulcer la picior<\/strong> \u2014 cronic, dureros, cu cicatrizare lent\u0103; afecteaz\u0103 ~5% dintre utilizatorii pe termen lung; poate necesita reducerea dozei sau \u00eentreruperea tratamentului<\/li>\n<li><strong>Carcinom cutanat cu celule scuamoase<\/strong> \u2014 utilizatori pe termen lung, \u00een special cei cu piele deschis\u0103; evaluare dermatologic\u0103 anual\u0103 \u0219i utilizare riguroas\u0103 a protec\u021biei solare<\/li>\n<li>Macrocitoza (MCV crescut) \u2014 a\u0219teptat\u0103, marker de conformitate, nu reprezint\u0103 o problem\u0103<\/li>\n<li>Fibroz\u0103 pulmonar\u0103 (rar\u0103)<\/li>\n<li>Hiperuricemie, gut\u0103<\/li>\n<li>Posibil\u0103 leucemie secundar\u0103 la pacien\u021bii cu policitemie vera pe termen lung (controversat)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Avertismente<\/h2>\n<ul>\n<li><strong>Sarcina:<\/strong> teratogen. Contraceptie puternic\u0103 pe toat\u0103 durata tratamentului \u0218I timp de 6 luni dup\u0103 ultima doz\u0103, at\u00e2t la pacien\u021bii de sex masculin c\u00e2t \u0219i feminin.<\/li>\n<li><strong>Al\u0103ptarea:<\/strong> eliminat prin laptele matern \u2014 evita\u021bi.<\/li>\n<li><strong>Afectare renal\u0103:<\/strong> reduce\u021bi doza pentru eGFR &lt; 60 mL\/min.<\/li>\n<li><strong>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103:<\/strong> precau\u021bie.<\/li>\n<li><strong>Screening pentru cancer de piele:<\/strong> evaluare dermatologic\u0103 anual\u0103 pentru utilizatorii pe termen lung; protec\u021bie solar\u0103 riguroas\u0103 zilnic\u0103.<\/li>\n<li><strong>Vaccin\u0103ri:<\/strong> vaccinurile cu virus viu contraindicate; vaccinurile inactivate sigure \u0219i recomandate.<\/li>\n<li><strong>co-infec\u021bie cu HIV:<\/strong> combina\u021bia hidroxiuree + didanozin\u0103 a provocat pancreatit\u0103 fatal\u0103 \u2014 evita\u021bi.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;\">Combina\u021bi cu<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">Efect<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">Ce s\u0103 face\u021bi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Didanozin\u0103 (antiretroviral HIV)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Pancreatit\u0103 fatal\u0103 raportat\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Evita\u021bi absolut combina\u021bia.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alte medicamente mielosupresoare (chimioterapie, imunosupresoare)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Suprimare medular\u0103 aditiv\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Supraveghere specializat\u0103; monitorizare strict\u0103 a hemogramei complete.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vaccinuri cu virus viu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Risc de infec\u021bie diseminat\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Contraindicated.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Allopurinol sau febuxostat<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Util \u00een hiperuricemie\/gut\u0103 cauzat\u0103 de turnover celular<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Adesea coprescris.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<ul>\n<li>La temperatur\u0103 camerei, 15\u201330\u00b0C, \u00een blisterul original.<\/li>\n<li>P\u0103stra\u021bi \u00een afara accesului copiilor, femeilor \u00een v\u00e2rst\u0103 de reproducere, animalelor de companie.<\/li>\n<li>\u00cengrijitorii care manipuleaz\u0103 capsule sparte trebuie s\u0103 poarte m\u0103nu\u0219i \u2014 pulberea este citotoxic\u0103.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Alternative conexe pe MedsBase<\/h2>\n<p>Alte medicamente oncologice disponibile \u00eempreun\u0103 cu acest produs:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ondrea\/\"><strong>Ondrea (hidroxiuree 500 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/riborea\/\"><strong>Riborea (hidroxiuree 500 mg)<\/strong><\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/medsbase.com\/ro\/anti-cancer-medication\/\">R\u0103sfoi\u021bi toate medicamentele anti-cancer \u2192<\/a><\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Cum ajut\u0103 Hydrosar \u00een anemia cu celule \u00een secer\u0103?<\/h3>\n<p>Hidroxiureea este cel mai important medicament modificator de boal\u0103 pentru sindromul falciform. Cre\u0219te nivelul hemoglobinei fetale (HbF), care previne falcizarea eritrocitelor. Efecte: <strong>~50% reducere a crizelor vaso-oclusive, mai pu\u021bine spitaliz\u0103ri, mai pu\u021bin sindrom toracic acut, necesar redus de transfuzii, supravie\u021buire \u00eembun\u0103t\u0103\u021bit\u0103<\/strong>. Majoritatea pacien\u021bilor observ\u0103 beneficii clinice dup\u0103 8\u201312 s\u0103pt\u0103m\u00e2ni de titrare a dozei; beneficiul maxim la 6\u201312 luni. Subutilizat la nivel global \u00een ciuda unei baze puternice de dovezi \u2014 consulta\u021bi hematologul dac\u0103 ave\u021bi sindrom falciform \u0219i nu vi s-a oferit hidroxiuree.<\/p>\n<h3 class=\"wp-block-heading\">Ce analize de s\u00e2nge am nevoie \u00een timpul tratamentului cu Hydrosar?<\/h3>\n<p><strong>Obligatoriu:<\/strong> Hemogram\u0103 complet\u0103 la fiecare 2 s\u0103pt\u0103m\u00e2ni ini\u021bial (s\u0103pt\u0103m\u00e2nal \u00een timpul titr\u0103rii pentru sindrom falciform), apoi lunar odat\u0103 stabilizat. U&amp;E + teste hepatice la fiecare 1\u20133 luni. Pacien\u021bii cu sindrom falciform: m\u0103surare HbF, num\u0103r\u0103toare de reticulocite. Suspendare sau reducere de doz\u0103 pentru ANC &lt; 2.000\/\u00b5L, trombocite &lt; 80.000\/\u00b5L sau Hb &lt; 4,5 g\/dL.<\/p>\n<h3 class=\"wp-block-heading\">De ce este Hydrosar asociat cu ulcera\u021biile la picioare?<\/h3>\n<p>Ulcerele cronice, dureroase de picior afecteaz\u0103 ~5% dintre utilizatorii pe termen lung de hidroxiuree, \u00een special \u00een regiunea maleolar\u0103 (glezn\u0103). Mecanismul este neclar (probabil microvascular). Se vindec\u0103 lent \u0219i pot necesita reducerea dozei sau \u00eentreruperea hidroxiureei. Notifica\u021bi imediat medicul dac\u0103 dezvolta\u021bi un ulcer de picior sub hidroxiuree \u2014 nu am\u00e2na\u021bi.<\/p>\n<h3 class=\"wp-block-heading\">Hydrosar poate provoca cancer?<\/h3>\n<p>Utilizarea pe termen lung a hidroxiureei cre\u0219te u\u0219or riscul de <strong>carcinom cutanat cu celule scuamoase<\/strong>, \u00een special la pacien\u021bii cu piele deschis\u0103 la culoare. Evaluare dermatologic\u0103 anual\u0103 a \u00eentregii piei, protec\u021bie solar\u0103 cu spectru larg zilnic, evitarea soarelui. Preocuparea istoric\u0103 legat\u0103 de <strong>leucemie secundar\u0103 \u00een policitemia vera<\/strong> la utilizarea pe termen lung a hidroxiureei este dezb\u0103tut\u0103 \u2014 datele moderne la scar\u0103 larg\u0103 sugereaz\u0103 c\u0103 riscul este sc\u0103zut \u0219i c\u0103 PV \u00een sine poart\u0103 un risc inherent de transformare leucemic\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 r\u0103m\u00e2n \u00eens\u0103rcinat\u0103 \u00een timp ce iau Hydrosar?<\/h3>\n<p>Hidroxiureea este teratogen\u0103. Contraceptia fiabil\u0103 este obligatorie pe tot parcursul tratamentului \u0218I pentru cel pu\u021bin <strong>6 luni dup\u0103 ultima doz\u0103, at\u00e2t la pacien\u021bii de sex masculin, c\u00e2t \u0219i la cei de sex feminin<\/strong>. Discuta\u021bi planificarea familiei cu hematologul dumneavoastr\u0103 \u00eenainte de a \u00eencepe tratamentul. \u00cen anemie falciform\u0103, hidroxiureea este uneori \u00eentrerupt\u0103 \u00een timpul sarcinii planificate, cu monitorizare atent\u0103.<\/p>\n<h3 class=\"wp-block-heading\">De ce cre\u0219te MCV-ul meu la administrarea Hydrosar?<\/h3>\n<p>Macrocitoza (cre\u0219terea MCV) este un efect a\u0219teptat \u0219i util \u2014 indic\u0103 faptul c\u0103 lua\u021bi medicamentul \u00een mod constant. Medicii folosesc MCV ca marker de conformitate \u00een anemia falciform\u0103. Cre\u0219terea este benign\u0103 \u0219i nu este asociat\u0103 cu nicio problem\u0103 clinic\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Pot deschide o capsul\u0103 dac\u0103 nu o pot \u00eenghi\u021bi?<\/h3>\n<p>Este recomandat s\u0103 evita\u021bi acest lucru \u2014 pulberea este citotoxic\u0103 \u0219i d\u0103un\u0103toare la contactul cu pielea, ochii sau sistemul respirator. Dac\u0103 este absolut necesar, \u00eengrijitorul trebuie s\u0103 poarte m\u0103nu\u0219i, s\u0103 lucreze \u00eentr-o zon\u0103 bine ventilat\u0103 \u0219i s\u0103 disperseze con\u021binutul \u00eentr-o cantitate mic\u0103 de ap\u0103 pentru ca pacientul s\u0103 o bea imediat. Sp\u0103la\u021bi-v\u0103 m\u00e2inile \u0219i suprafe\u021bele dup\u0103 aceea. Un farmacist specialist poate preg\u0103ti o suspensie lichid\u0103 ca alternativ\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua Hydrosar concomitent cu antiretroviralele pentru HIV?<\/h3>\n<p>Majoritatea terapiei antiretrovirale sunt compatibile. Combina\u021bia periculoas\u0103 este <strong>hidroxiuree + didanozin\u0103<\/strong>, care a cauzat pancreatit\u0103 fatal\u0103. Informa\u021bi fiecare medic prescriptor despre ambele medicamente \u0219i asigura\u021bi-v\u0103 c\u0103 nu ave\u021bi didanozin\u0103 \u00een regimul vostru.<\/p>\n<p><!-- medsbase-why-order --><\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Fiecare lot este procurat de la un <strong>produc\u0103tor certificat WHO-GMP<\/strong>. Comenzile sunt expediate \u00een ambalaje simple, f\u0103r\u0103 marc\u0103, de la partenerii no\u0219tri de onorare \u0219i acoperite de <a href=\"\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a>: dac\u0103 un colet nu ajunge \u00een 20 de zile lucr\u0103toare, trimitem gratuit o nou\u0103 comand\u0103, f\u0103r\u0103 \u00eentreb\u0103ri.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Medicamente Anticanceroase Asem\u0103n\u0103toare<\/h3>\n<p>Alte medicamente oncologice disponibile \u00eempreun\u0103 cu acest produs:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ondrea\/\">Ondrea (hidroxiuree 500 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/endoxan\/\">Endoxan (ciclosfosfamid\u0103 50 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/imatib\/\">Imatib (imatinib 100\/400 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/veenat\/\">Veenat (imatinib 100\/400 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/folitrax\/\">Folitrax (metotrexat 2,5\/7,5\/10 mg)<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Trateaz\u0103 anemia cu celule \u00een secer\u0103<br \/>\n\u2705 Reduce frecven\u021ba crizelor dureroase<br \/>\n\u2705 Regleaz\u0103 produc\u021bia de celule sanguine<br \/>\n\u2705 Previne formarea cheagurilor<br \/>\n\u2705 Reduce riscul de accident vascular cerebral<\/p>\n<p>Hydrosar con\u021bine hidroxiuree.<\/p>","protected":false},"featured_media":57574,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3595,3141,3223],"product_tag":[4331,4315],"class_list":{"0":"post-57573","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-cancer-medication","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_tag-hydrosar","10":"product_tag-hydroxyurea","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/57573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=57573"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/57574"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=57573"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=57573"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=57573"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=57573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}